Cited by 279Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsMedical Imaging Techniques and Applications

The DOI matches its Crossref record; 57 of the 59 references it cites were found in a registry or an index.

Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer’s Disease Neuroimaging Initiative (ADNI)

Open access

Langbaum, Jessica B.S., Chen, Kewei, Lee, Wendy, Reschke, Cole, Bandy, Dan, Fleisher, Adam S., Alexander, Gene E., Foster, Norman L., Weiner, Michael W., Koeppe, Robert A., Jagust, William J., Reiman, Eric M.·2009·NeuroImage

DOI 10.1016/j.neuroimage.2008.12.072PMC PMC2886795

Open this paper in CoChat — free account

Abstract

In mostly small single-center studies, Alzheimer's disease (AD) is associated with characteristic and progressive reductions in fluorodeoxyglucose positron emission tomography (PET) measurements of the regional cerebral metabolic rate for glucose (CMRgl). The AD Neuroimaging Initiative (ADNI) is acquiring FDG PET, volumetric magnetic resonance imaging, and other biomarker measurements in a large longitudinal multi-center study of initially mildly affected probable AD (pAD) patients, amnestic mild cognitive impairment (aMCI) patients, who are at increased AD risk, and cognitively normal controls (NC), and we are responsible for analyzing the PET images using statistical parametric mapping (SPM). Here we compare baseline CMRgl measurements from 74 pAD patients and 142 aMCI patients to those from 82 NC, we correlate CMRgl with categorical and continuous measures of clinical disease severity, and we compare apolipoprotein E (APOE) varepsilon4 carriers to non-carriers in each of these subject groups. In comparison with NC, the pAD and aMCI groups each had significantly lower CMRgl bilaterally in posterior cingulate, precuneus, parietotemporal and frontal cortex. Similar reductions were observed when categories of disease severity or lower Mini-Mental State Exam (MMSE) scores were correlated with lower CMRgl. However, when analyses were restricted to the pAD patients, lower MMSE scores were significantly correlated with lower left frontal and temporal CMRgl. These findings from a large, multi-site study support previous single-site findings, supports the characteristic pattern of baseline CMRgl reductions in AD and aMCI patients, as well as preferential anterior CMRgl reductions after the onset of AD dementia.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.neuroimage.2008.12.072

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Co-Planar Stereotaxic Atlas of the Human Brain
Talairach, J., & Tournoux, P. (1988) · Medical Entomology and Zoology · Cited by 11,798
Co-planar stereotaxic atlas of the human brain
Laitinen, L. (1989) · Clinical Neurology and Neurosurgery · doi:10.1016/0303-8467(89)90128-5 · Cited by 7,565
Current concepts in mild cognitive impairment
Petersen, R. C., Doody, R., Kurz, A., Mohs, R. C., Morris, J. C., Rabins, P. V., Ritchie, K., Rossor, M., Thal, L., & Winblad, B. (2001) · Archives of Neurology · doi:10.1001/archneur.58.12.1985 · Cited by 4,781
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496
Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease
Minoshima, S., Giordani, B., Berent, S., Frey, K. A., Foster, N. L., & Kuhl, D. E. (1997) · Annals of Neurology · doi:10.1002/ana.410420114 · Cited by 1,802
Self-citation
Preclinical Evidence of Alzheimer's Disease in Persons Homozygous for the ε4 Allele for Apolipoprotein E
Reiman, E. M., Caselli, R. J., Yun, L. S., Chen, K., Bandy, D., Minoshima, S., Thibodeau, S. N., & Osborne, D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603213341202 · Cited by 1,366
Self-citation
Ways toward an early diagnosis in Alzheimer’s disease: the Alzheimer’s Disease Neuroimaging Initiative (ADNI)
Mueller, S. G., Weiner, M. W., Thal, L. J., Petersen, R. C., Jack, C. R., Jagust, W., Trojanowski, J. Q., Toga, A. W., & Beckett, L. (2005) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2005.06.003 · Cited by 1,233
Self-citation
A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET.
(1995) · PubMed Central · doi:10.2967/jnumed.120.252510a · Cited by 996
Self-citation
Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia
Reiman, E. M., Chen, K., Alexander, G. E., Caselli, R. J., Bandy, D., Osborne, D., Saunders, A. M., & Hardy, J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2635903100 · Cited by 977
Self-citation

Flagged first, then by citations

Show all 59 references

2 of the 59 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

De, 2001, Hippocampal formation glucose metabolism and volume losses in MCI and AD, Neurobiol. Aging, 22, 529, 10.1016/S0197-4580(01)00230-5 · DOI · Paper page

Sorted by citations

Items 201–279 of 279

Optimal likelihood-ratio multiple testing with application to Alzheimer’s disease and questionable dementia
Lee, D., Kang, H., Kim, E., Lee, H., Kim, H., Kim, Y. K., Lee, Y., & Lee, D. S. (2015) · BMC Medical Research Methodology · doi:10.1186/1471-2288-15-9 · Cited by 10
Prognostic model for predicting Alzheimer’s disease conversion using functional connectome manifolds
Kim, S., Kim, M., Lee, J., Park, B., & Park, H. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01589-3 · Cited by 11
Classification of Mild Cognitive Impairment by Fusing Neuroimaging and Gene Expression Data
Lyu, Y., Yu, X., Zhang, L., & Zhu, D. (2021) · International Conference on PErvasive Technologies Related to Assistive Environments (PETRA) · doi:10.1145/3453892.3453906 · Cited by 9
Distinct Functional and Metabolic Alterations of DMN Subsystems in Alzheimer’s Disease: A Simultaneous FDG-PET/fMRI Study
Guan, Z., Zhang, M., Zhang, Y., Li, B., & Li, Y. (2021) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc46164.2021.9629472 · Cited by 9
Erratum: Categorize, Cluster, and Classify: A 3-C Strategy for Scientific Discovery in the Medical Informatics Platform of the Human Brain Project
Galili, T., Mitelpunkt, A., Shachar, N., Marcus-Kalish, M., & Benjamini, Y. (2014) · Lecture notes in computer science · doi:10.1007/978-3-319-11812-3_31 · Cited by 10
Are Women with Polycystic Ovary Syndrome at Increased Risk of Alzheimer Disease? Lessons from Insulin Resistance, Tryptophan and Gonadotropin Disturbances and Their Link with Amyloid-Beta Aggregation
Sobczuk, J., Paczkowska, K., Andrusiów, S., Bolanowski, M., & Daroszewski, J. (2024) · Biomolecules · doi:10.3390/biom14080918 · Cited by 8
The Neuropsychological Correlates of Brain Perfusion and Gray Matter Volume in Alzheimer’s Disease
Tai, H., Hirano, S., Sakurai, T., Nakano, Y., Ishikawa, A., Kojima, K., Li, H., Shimada, H., Kashiwado, K., Mukai, H., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200676 · Cited by 7
Feed-forward hierarchical model of the ventral visual stream applied to functional brain image classification
Keator, D. B., Fallon, J. H., Lakatos, A., Fowlkes, C. C., Potkin, S. G., Ihler, A., & Initiative, A. D. N. (2012) · Human Brain Mapping · doi:10.1002/hbm.22149 · Cited by 7
Atypical Localization and Dissociation between Glucose Uptake and Amyloid Deposition in Cognitively Normal APOE*E4 Homozygotic Elders Compared with Patients with Late-Onset Alzheimer’s Disease
Pardo, J. V., Lee, J. T., & Initiative, A. D. N. (2018) · eNeuro · doi:10.1523/eneuro.0396-17.2018 · Cited by 8
Effects of the 5-HT2A and DRD3 genotypes on cortical morphology and functional connectivity density in drug-naïve first episode schizophrenia
Kang, Y., Zhang, W., Lv, Y., Cai, S., Xu, H., Wang, J., & Huang, L. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.11.058 · Cited by 7
Using Neuroimaging to Inform Clinical Practice for the Diagnosis and Treatment of Mild Cognitive Impairment
Hampstead, B. M., & Brown, G. S. (2013) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2013.07.007 · Cited by 7
Inclusion criteria provide heterogeneity in baseline profiles of patients with mild cognitive impairment: comparison of two prospective cohort studies
Kawashima, S., Ito, K., Kato, T., & the SEAD-J Study Group (2012) · BMJ Open · doi:10.1136/bmjopen-2011-000773 · Cited by 6
Amnestic mild cognitive impairment
Butler, C., & Ahmed, S. (2016) · Cambridge University Press eBooks · doi:10.1017/9781139924771.016 · Cited by 6
The relationship of glucose-stimulated insulin secretion to cerebral glucose metabolism and cognition in healthy middle-aged and older adults
Ennis, G. E., Kohli, A., Jonaitis, E. M., Betthauser, T. J., Oh, J. M., Taylor, C. E., Chin, N. A., Koscik, R. L., Christian, B. T., Asthana, S., et al. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.04.028 · Cited by 6
A Genome-wide study on the genetic and causal effects of smoking in neurodegeneration
Chen, C., Zhu, S., Zheng, Z., Ding, X., Shi, W., Xia, T., & Gu, X. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06688-9 · Cited by 5
The Role of Neuroimaging in the Assessment of the Cognitively Impaired Elderly
Kollack‐Walker, S., Liu, C. Y., & Fleisher, A. (2017) · Neurologic Clinics · doi:10.1016/j.ncl.2017.01.010 · Cited by 6
Self-citation
Differential impact of body mass index and leptin on baseline and longitudinal positron emission tomography measurements of the cerebral metabolic rate for glucose in amnestic mild cognitive impairment
Weise, C. M., Chen, K., Chen, Y., Devadas, V., Su, Y., & Reiman, E. M. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1031189 · Cited by 5
Self-citation
A PET study of discrimination of cerebral glucose metabolism in Alzheimer's disease and mild cognitive impairment
Sun, H., Hu, B., Yao, Z., & Jackson, M. (2013) · International Conference on Biomedical Engineering and Informatics (BMEI) · doi:10.1109/bmei.2013.6746897 · Cited by 5
Evaluation of Early Dementia (Mild Cognitive Impairment)
Osorio, R. S., Berti, V., Mosconi, L., Li, Y., Glodzik, L., Santi, S. D., & de Leon, M. J. (2010) · PET Clinics · doi:10.1016/j.cpet.2009.12.003 · Cited by 5
Magnetic resonance imaging of Alzheimer’s disease: from diagnosis to therapeutic evaluation
Gu, X., Jiang, Z.-F., & Huang, H. (2010) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-010-0276-8 · Cited by 5
Neuroimaging of Alzheimer’s Disease, Mild Cognitive Impairment, and Other Dementias
Risacher, S. L., & Saykin, A. J. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6373-4_19 · Cited by 5
APOE4 and infectious diseases jointly contribute to brain glucose hypometabolism, a biomarker of Alzheimer’s pathology: New findings from the ADNI
Rajendrakumar, A. L., Arbeev, K. G., Bagley, O., Duan, M., Yashin, A. I., Ukraintseva, S. V., & Initiative, A. D. N. (2025) · PLoS ONE · doi:10.1371/journal.pone.0316808 · Cited by 4
Assessing the metabolism of the olfactory circuit by use of 18F-FDG PET-CT imaging in patients suspected of suffering from Alzheimer’s disease or frontotemporal dementia
Loewenstein, D. S. L., van Grinsven, M., de Pont, C., DAUTZENBERG, P. L. J., van Strien, A. M., & Henssen, D. J. H. A. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01604-7 · Cited by 4
Cognitive and neuroimaging outcome of very prodromal dementia with Lewy bodies
Blanc, F., Bouteloup, V., Paquet, C., Marie Chupin, A., Pasquier, F., Gabelle, A., Ceccaldi, M. P., de Sousa, P. L., Krolak‐Salmon, P., David, R., et al. (2025) · GeroScience · doi:10.1007/s11357-025-01701-x · Cited by 4
Multilayer Clustering: Biomarker Driven Segmentation of Alzheimer's Disease Patient Population
Gamberger, D., Ženko, B., Mitelpunkt, A., & Lavrač, N. (2015) · International Work-Conference on Bioinformatics and Biomedical Engineering · doi:10.1007/978-3-319-16483-0_13 · Cited by 4
APOE4 Exerts Partial Diet-dependent Effects on Energy Expenditure and Skeletal Muscle Mitochondrial Pathways in a Preclinical Model
Johnson, C. N., Lysaker, C. R., Gast, E. C., McCoin, C. S., Kemna, R. E., Fuller, K. N. Z., Kugler, B. A., Franczak, E., Csikós, V., Allen, J., et al. (2025) · Function · doi:10.1093/function/zqaf017 · Cited by 3
Neurovascular and metabolic dysfunction with cell type-specific transcriptomic changes in presymptomatic 5XFAD mice
Yao, M., Sun, N., Linville, R. M., Wei, Z., Kakazu, A., Ouyang, Y., Li, R., Du, L., Wang, H., Zhou, Y., et al. (2026) · Fluids and Barriers of the CNS · doi:10.1186/s12987-025-00756-4 · Cited by 6
Identification of Gender Specific Biomarkers for Alzheimer’s Disease
Gamberger, D., Ženko, B., Mitelpunkt, A., Nada Lavrač, A., & Initiative, A. D. N. (2015) · Lecture notes in computer science · doi:10.1007/978-3-319-23344-4_6 · Cited by 3
A Fast and Automatic Approach to Extract the Brain and Midsagittal Lines from FDG-PET Head Scans
Qian, G., Luo, S., Jin, J. S., Park, M., Li, J., & Nowinski, W. L. (2009) · International Conference on Information Science and Engineering · doi:10.1109/icise.2009.28 · Cited by 3
Potential Neuroprotective Strategies using Smart Drug Delivery Systems for Alzheimer’s Disease
Khan, J., Yadav, S., & Alam, A. (2023) · Infectious Disorders - Drug Targets · doi:10.2174/0118715265254985231012065058 · Cited by 2
Diagnostic performance of the cingulate island sign ratio for differentiating dementia with Lewy bodies from Alzheimer's disease changes depending on the mini-mental state examination score
Asahara, Y., Kameyama, M., Ishii, K., & Ishibashi, K. (2023) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2023.122782 · Cited by 2
Galactose Counteracts Hypoglycemia-Induced Decline of Cholinergic Neurons at Low pH in Organotypic Rat Brain Slices of the Basal Nucleus of Meynert
Pirchl, M., & Humpel, C. (2011) · Pharmacology · doi:10.1159/000331861 · Cited by 2
Demenz mit Lewy-Körpern
Dodel, R. C., Koschel, J., Lorenzl, S., Levin, J., van Eimeren, T., & Höglinger, G. U. (2018) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/a-0696-6249 · Cited by 2
Towards the Identification of Disease Signatures
Venetis, T., Ailamaki, A., Heinis, T., Karpathiotakis, M., Kherif, F., Mitelpunkt, A., & Vassalos, V. (2015) · Brain Informatics and Health · doi:10.1007/978-3-319-23344-4_15 · Cited by 4
Molecular imaging in cognitive impairment: the relevance of cognitive reserve, importance of multisite longitudinal trials and challenges of standardised analysis
Lucignani, G., & Perneczky, R. (2009) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1361-0 · Cited by 2
Extended Talairach Landmarks on Neuroimages for Atlas Registration
Qian, G., Luo, S., Jin, J. S., & Nowinski, W. L. (2010) · International Conference on Bioinformatics and Biomedical Engineering · doi:10.1109/icbbe.2010.5517057 · Cited by 2
Cell Type-Specific Contributions to Impaired Blood-Brain Barrier and Cerebral Metabolism in Presymptomatic 5XFAD MicePreprint
Yao, M., Sun, N., Linville, R. M., Wei, Z., Kakazu, A., Ouyang, Y., Li, R., Du, L., Wang, H., Zhou, Y., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.23.650260 · Cited by 2
The role of nuclear medicine in central nervous system evaluation
Shadmani, G., Swingle, C. A., & Coffman, C. H. (2025) · The Neuroradiology Journal · doi:10.1177/19714009251345100 · Cited by 1
Leading role of 18F-FDG-PET imaging in early diagnosis of Alzheimer’s disease: an overview
Treglia, G., & Cason (2011) · Research and Reports in Nuclear Medicine · doi:10.2147/rrnm.s16142 · Cited by 1
Positron emission tomography inter-scanner differences in dopamine D2 receptor binding measured with [11C]FLB457
Kodaka, F., Ito, H., Shidahara, M., Takano, H., Takahashi, H., Arakawa, R., Nakayama, K., & Suhara, T. (2010) · Annals of Nuclear Medicine · doi:10.1007/s12149-010-0407-5 · Cited by 1
Möglichkeiten moderner Bildgebungstechnologien im Rahmen der Frühdiagnostik von Alzheimererkrankung
Unschuld, P. G. (2015) · Therapeutische Umschau · doi:10.1024/0040-5930/a000674 · Cited by 1
Advances in Alzheimer’s Disease Management
Gauthier, S. G., & Rosa‐Neto, P. (2012) · doi:10.2217/9781780840840 · Cited by 1
What is the Role of Positron Emission Tomography in Drug Development?
McCarthy, T. J. (2012) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789814317740_0004 · Cited by 1
Neuroprotective potential of gliflozins
Kokin, A. S., & Суплотова, Л. А. (2023) · Diabetes Mellitus · doi:10.14341/dm13085 · Cited by 2
Zero-Shot Bias Correction: Efficient MR Image Inhomogeneity Reduction without Any Data
Yang, H., Timkó, E., & Fernandez, B. (2025) · IEEE International Symposium on Biomedical Imaging (ISBI) · doi:10.1109/isbi60581.2025.10980960 · Cited by 1
Clinical aspects of dementia
Golden, E. C., & Josephs, K. A. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107588660.002 · Cited by 1
FDG-PET in Dementia
Aiello, M., Cavaliere, C., Inglese, M., Monti, S., & Salvatore, M. (2016) · Springer eBooks · doi:10.1007/978-3-319-31614-7_6 · Cited by 1
Rapid and automatic atlas-based approach of Alzheimer's disease assessment by positron emission tomography neuroimages
Qian, G., Shen, X., Luo, S., Jin, J. S., & Nowinski, W. L. (2010) · IEEE International Conference on Cognitive Informatics · doi:10.1109/coginf.2010.5599709 · Cited by 1
High Dimensional Dependent Data Analysis for Neuroimaging.
Shu, H. (2016) · Deep Blue (University of Michigan) · Cited by 1
Unraveling the Biologic Basis for Domain-Specific Cognitive Decline
Risacher, S. L. (2017) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2017.04.007 · Cited by 1
Current awareness in geriatric psychiatry
(2009) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2120 · Cited by 1
Meta analysis of glucose metabolism across Alzheimer’s, Parkinson’s and ALS Reveals emergence of adaptive brain glucometabolic responses and associated neurological functional profilesPreprint
Raikes, A., Garza, M., Murrell, A. N., & Brinton, R. D. (2026) · medRxiv · doi:10.64898/2026.04.07.26350339 · Cited by 1
Manifold Forests for Multi-modality Classification of Alzheimer’s Disease
Gray, K. R., Aljabar, P., Heckemann, R. A., Hammers, A., & Rueckert, D. (2013) · Advances in computer vision and pattern recognition · doi:10.1007/978-1-4471-4929-3_18 · Cited by 1
[18F]Fluorodeoxyglucose Positron Emission Tomography in Alzheimer Disease and Related Disorders
MIYAZAWA, N., & Shinohar, T. (2012) · InTech eBooks · doi:10.5772/30326
Imaging of the Geriatric Brain
Apostolova, L. G., Fleisher, A., Drzezga, A. E., Nair, A. K., & Sabbagh, M. N. (2014) · Wiley eBooks · doi:10.1002/9781118730676.ch7
Self-citation
Regularized Functional Regression Models with Applications to Brain Imaging.
Xuejing, W. (2013) · Deep Blue (University of Michigan)
F - FDG PET in patients with Alzheimer's disease and amnestic mild cognitive impairment ·Neuroimaging Study of Alzheimer's Disease·
Shi, Z., Ying, W., Liu, S., Liu, S., Zhou, Y., Wang, J., Gao, S., & Ji, Y. (2014) · DOAJ (DOAJ: Directory of Open Access Journals)
Modality Neutral Techniques for Brain Image Understanding
Keator, D. B. (2012) · Lecture notes in computer science · doi:10.1007/978-3-642-34713-9_11
Functional imaging of Alzheimer's disease
Taler, V., & Saykin, A. J. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511782091.025
O4‐01‐02: Meta‐analytic comparison of PiB‐PET and FDG‐PET results in Alzheimer's disease and MCI
He, W., Xu, J., Shi, J.-Q., & Radua, J. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.05.1635
Novel statistical models for complex data structures
Li, J., & Huang, S. (2012)
“Personal Training”
Tsolaki, A. (2015) · Advances in psychology, mental health, and behavioral studies (APMHBS) book series · doi:10.4018/978-1-4666-8234-4.ch002
Atlas-based assessment and diagnosis of Alzheimer's Disease from neuroimages
(615475), G. Q. (2010) · NOVA (University of Newcastle Australia)
Diagnosis of Alzheimer’s disease
Rosa‐Neto, P., Rowley, J., Leuzy, A., Mohades, S., Shin, M., Dauar, M. T., & Gauthier, S. G. (2012) · doi:10.2217/ebo.12.66
Neuroimaging in Dementia
Ong, K. T. (2018) · OBM Geriatrics · doi:10.21926/obm.geriatr.1803011
Discovering Biomarkers of Alzheimer's Disease by Statistical Learning Approaches
Long, J. (2019) · PEARL (University of Plymouth) · doi:10.24382/645
WITHDRAWN: A survey on functional and cognitive assessment for diagnosing neurodegenerative disorders
Rajendiran, M., Kumar, K. P. S., Kumar, R. N., & Nair, S. (2021) · Materials Today Proceedings · doi:10.1016/j.matpr.2021.01.221
Retracted
Physical Exercise and the Resting Brain
Hugenschmidt, C. E., Laurienti, P. J., & Burdette, J. H. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3293-7_16
Ketotherapeutics to Rescue Brain Energy Deficits
Myette‐Côté, É., Castellano, C., Fortier, M., St‐Pierre, V., & Cunnane, S. C. (2022) · Oxford University Press eBooks · doi:10.1093/med/9780197501207.003.0017
References
(2016) · Elsevier eBooks · doi:10.1016/b978-0-12-804538-1.00036-5
APOE4 and Infectious Diseases Jointly Contribute to Brain Glucose Hypometabolism, a Biomarker of Alzheimer’s Pathology: New Findings from the ADNIPreprint
Rajendrakumar, A. L., Arbeev, K. G., Bagley, O., Duan, M., Yashin, A. I., Ukraintseva, S. V., & Initiative, A. D. N. (2024) · medRxiv · doi:10.1101/2024.09.13.24313582
Putative Survival Advantages in Infant, Child, and Young Adult Apolipoprotein ε4 Carriers
Smith, C. J., Ashford, J. W., & Perfetti, T. A. (2025) · Springer eBooks · doi:10.1007/978-3-031-52641-1_13-1
Functional connectivity density as a biomarker for Alzheimer's disease: Distinct neural mechanisms in young‐ and late‐onset subtypes
Chang, H., Hsu, S., Huang, S., Huang, C., Lee, C.-C., & Chang, C. (2026) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.70021
Brain Networks and Non-invasive Brain Stimulation in Alzheimer’s Disease: From Mechanistic Insights to Clinical Applications
Ma, J., Lu, J., Guo, Q.-H., Hua, X., & Xu, J. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1014748
Probabilistic Joint and Individual Variation Explained (ProJIVE) for Data Integration
Murden, R., Tian, G., Qiu, D., Risk, B. B., & Initiative, F. T. A. D. N. (2026) · Journal of Computational and Graphical Statistics · doi:10.1080/10618600.2026.2639081 · Cited by 1
Modifications du sommeil liées à l'âge : liens avec la cognition et les biomarqueurs du vieillissement et de la maladie d'Alzheimer en neuroimagerie
André, C. (2019) · theses.fr (ABES) · doi:10.70675/a6a04137zbf97z47aazaa36z0de2f4b90657
Vers une meilleure compréhension des facteurs psychoaffectifs (anxiété et dépression) dans le vieillissement normal et pathologique : liens avec la cognition et la neuroimagerie multimodale
Moulinet, I. (2020) · theses.fr (ABES) · doi:10.70675/45bad93dz6eeez45d1z8d85z5e83196b607c
3S-HS et HS3ST2 dans les macrophages humains : implication dans le diagnostic de la maladie d'Alzheimer
Abdelouahab, O. B. (2021) · theses.fr (ABES) · doi:10.70675/97f4885fz3f5cz4234zb8e2ze3fa7c4e3d41
Robust nonlinear multimodal classification of Alzheimer's disease based on GMM
Wang, Z. (2020) · Journal of Information and Computing Science · doi:10.4208/jics.v15.n1.p16

IC‐P1‐036: Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's disease neuroimaging initiative
Lee, W., Langbaum, J. B. S., Chen, K., Recshke, C., Bandy, D. J., Alexander, G. E., Foster, N. L., Weiner, M. W., Koeppe, R. A., Jagust, W., et al. (2008) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2008.05.047
Self-citation
P2‐037: Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's disease neuroimaging initiative
Lee, W., Langbaum, J. B. S., Chen, K., Recshke, C., Bandy, D. J., Alexander, G. E., Foster, N. L., Weiner, M. W., Koeppe, R. A., Jagust, W., et al. (2008) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2008.05.1118
Self-citation
P‐024: The pattern and severity of FDG pet abnormalities in Alzheimer's disease and amnestic mild cognitive impairment: Preliminary findings from the Alzheimer's disease neuroimaging initiative
Chen, K., Reiman, E. M., Alexander, G. E., Smilovici, O., Lee, W., Reschke, C., Bandy, D., Foster, N., Weiner, M. W., Koeppe, R. A., et al. (2007) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2007.04.240 · Cited by 1
Self-citation
Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: Findings from the Alzheimer's Disease Neuroimaging Initiative
Chen, K., Langbaum, J. B. S., Fleisher, A., Ayutyanont, N., Reschke, C., Lee, W., Liu, X., Bandy, D., Alexander, G. E., Thompson, P. M., et al. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.02.064 · Cited by 173
Self-citation
O1–04–05: Six‐month cerebral metabolic declines in Alzheimer's disease, amnestic mild cognitive impairment and elderly normal control groups: Preliminary findings from the Alzheimer's disease neuroimaging initiative
Chen, K., Reiman, E. M., Alexander, G. E., Lee, W., Reschke, C., Smilovici, O., Bandy, D., Weiner, M. W., Koeppe, R. A., & Jagust, W. J. (2007) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2007.04.081
Self-citation

See all

Authors: Langbaum, J. B. S., Chen, K., Lee, W., Reschke, C., Bandy, D., Fleisher, A. S., Alexander, G. E., Foster, N. L., Weiner, M. W., Koeppe, R. A., Jagust, W. J., & Reiman, E. M.
Affiliations: Banner Alzheimer’s Institute (US)
University of Arizona (US)
University of California San Diego (US)
University of Utah (US)
San Francisco VA Medical Center (US)
University of Michigan (US)
University of California, Berkeley (US)
Translational Genomics Research Institute (US)
Corresponding author: Reiman, Eric M.
ORCID: Langbaum, Jessica B.S.
Chen, Kewei
Lee, Wendy
Fleisher, Adam S.
Alexander, Gene E.
Foster, Norman L.
Weiner, Michael W.
Koeppe, Robert A.
Jagust, William J.
Reiman, Eric M.
Venue: NeuroImage
Publisher: Elsevier BV
Published: 2009-05
Volume: 45
Issue: 4
Pages: 1107-1116
ISSN: 1053-8119 (ISSN-L)
DOI: 10.1016/j.neuroimage.2008.12.072
PMC: PMC2886795
OpenAlex: W2016228161
Cited by: 279
References: 59
Citations by year: 2026: 5 · 2025: 8 · 2024: 10 · 2023: 6 · 2022: 8 · 2021: 9 · 2020: 8 · 2019: 11 · 2018: 26 · 2017: 14 · 2016: 21 · 2015: 15 · 2014: 22 · 2013: 26 · 2012: 24
FWCI: 18.55
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: NeuroImage (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health (5u01ag024904-10)
National Institute on Aging (U01-AG-024904, P30AG019610, U19AG010483)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
Keywords: Alzheimer's disease, amnestic mild cognitive impairment, FDG-PET, regional cerebral glucose metabolism, posterior cingulate cortex, precuneus, frontal and temporal cortex, disease severity, Mini-Mental State Examination, APOE ε4, ADNI
MeSH terms: Aged, Alzheimer Disease, Cerebral Cortex, Cognition Disorders, Female, Humans, Male, Middle Aged, Reference Values, Sensitivity and Specificity, Statistics as Topic, Reproducibility of Results, Radiopharmaceuticals, Fluorodeoxyglucose F18, Positron-Emission Tomography

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer’s Disease Neuroimaging Initiative (ADNI)

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks